New roles for osteoclasts in bone

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 245-254

  Boyce, Brendan F ^a   Yao, Zhenqiang ^a   Zhang, Qian ^a   Guo, Roulin ^a   Lu, Yan ^a   Schwarz, Edward M ^a   Xing, Lianping ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bone resorption; Cytokine; Inflammatory arthritis; Osteoblast; Osteoclast

Indexed keywords

INTERLEUKIN 1;

BONE; BONE MARROW; BONE MARROW CELL; BONE MATRIX; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL MOTION; CONFERENCE PAPER; CYTOKINE RELEASE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MONONUCLEAR PHAGOCYTE; MULTINUCLEAR CELL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PHAGOCYTE; SECRETORY CELL;

EID: 37249067028     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.084     Document Type: Conference Paper

References (39)

1. ASAGIRI, M. & H. TAKAYANAGI. 2007. The molecular understanding of osteoclast differentiation. Bone 40: 251-264.
2. YAMASHITA, T. et al. 2007. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282: 18245-18253.
3. RODAN, G.A. & T.J. MARTIN. 1981. Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcif. Tiss. Int. 33: 349-351.
4. MARTIN, T.J. & N.A. SIMS. 2005. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11: 76-81.
5. BOYCE, B.F. & L. XING. 2006. Osteoclasts, no longer osteoblast slaves. Nat. Med. 12: 1356-1358.
6. ZHAO, C. et al. 2006. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4: 111-121.
7. DAVY, A. & P. SORIANO. 2005. Ephrin signaling in vivo: look both ways. Dev. Dyn. 232: 1-10.
8. LEE, S.H. et al. 2006. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med. 12: 1403-1409.
9. SUN-WADA, G.H. et al. 2003. Diversity of mouse proton-translocating ATPase: presence of multiple isoforms of the C, D and G subunits. Gene 302: 147-153.
10. YAGI, M. et al. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202: 345-351.
11. BONEWALD, L.F. 2007. Osteocytes as dynamic, multifunctional cells. Ann. N.Y. Acad. Sci.
12. TOMKINSON, A. et al. 1998. The role of estrogen in the control of rat osteocyte apoptosis. J. Bone Miner. Res. 13: 1243-1250.
13. VERBORGT, O., G.J. GIBSON, & M.B. SCHAFFLER. 2000. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J. Bone Miner. Res. 15: 60-67.
14. TATSUMI, S. et al. 2007. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5: 464-475.
15. SUDA, T. et al. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357.
16. LI, P. et al. 2004. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 50: 265-276.
17. JACQUIN, C. et al. 2006. Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Miner. Res. 21: 67-77.
18. HOROWITZ, M.C. & J.A. LORENZO. 2004. The origins of osteoclasts. Curr. Opin. Rheumatol. 16: 464-468.
19. RITCHLIN, C.T. et al. 2003. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111: 821-831.
20. YAO, Z. et al. 2006. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J. Biol. Chem. 281: 11846-11855.
21. BOYCE, B.F., E.M. SCHWARZ & L. XING. 2006. Osteoclast precursors: cytokinestimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18: 427-432.
22. O'KEEFE, R.J. et al. 1997. Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. Lab. Investig. 76: 457-465.
23. TAKAYANAGI, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83: 170-179.
24. GUO, R. et al. 2007. RANKL stimulates osteoclasts to release the lymphatic growth factor, VEGF-C, and enhances osteoclastic bone resorption through an autocrine mechanism J. Bone Miner. Res. 22: S30.
25. TAMMELA, T. et al. 2005. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65: 550-563.
26. PROULX, S.T. et al. 2007. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann. N.Y. Acad. Sci.
27. YAO, Z. et al. 2006. Osteoclast precursors induce their differentiation to osteoclasts by interacting with bone matrix and secreting cytokines. J. Bone Miner. Res. 21: S262.
28. JIMI, E. et al. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247: 84-93.
29. JIMI, E. et al. 1998. Activation of NF-κB is involved in the survival of osteoclasts promoted by Interleukin-1. J. Biol. Chem. 273: 8799-8805.
30. HUGHES, D.E. et al. 1995. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10: 1478-1487.
31. TAKAYANAGI, H. et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416: 744-749.
32. PERKINS, N.D. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8: 49-62.
33. YAO, Z. 2007. NF-κB2 limits TNF-induced osteoclastogenesis through precursor cell cycle regulation. J. Bone Miner. Res. 22: S42.
34. ADAMS, G.B. & D.T. SCADDEN. 2006. The hematopoietic stem cell in its place. Nat. Immunol. 7: 333-337.
35. CALVI, L.M. et al. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
36. WEBER, J.M. et al. 2006. Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone 39: 485-493.
37. TOLAR, J., S.L. TEITELBAUM & P.J. ORCHARD. 2004. Osteopetrosis. N. Engl. J. Med. 351: 2839-2849.
38. KOLLET, O. et al. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12: 657-664.
39. COTTLER-FOX, M.H. et al. 2003. Stem cell mobilization. Hematol. Am. Soc. Hematol. Educ. Prog. 419-437.